Welfare properties of restrictions to health care based on cost effectiveness

Health Economics

Volumn 20, Issue 1, 2011, Pages 101-110

  Levaggi, Laura ^a   Levaggi, Rosella ^b  

^a FREE UNIVERSITY OF BOZEN BOLZANO   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

cost effectiveness; welfare analysis

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; PRIORITY JOURNAL; WELFARE;

COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE; GREAT BRITAIN; HEALTH SERVICES ACCESSIBILITY; HUMANS; MODELS, STATISTICAL; PRIVATE SECTOR; PUBLIC SECTOR; SOCIAL WELFARE; STATE MEDICINE;

EID: 78650270729     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.1566     Document Type: Article

References (16)

1. Appleby J, Devlin N, Parkin D, Buxton M, Chalkidou K,. 2009. Searching for cost effectiveness thresholds in the NHS. Health Policy 91 (3): 239-245. ISSN 0168-8510, DOI: 10.1016/j.healthpol.2008.12.010.
2. Cuff K, Hurley J, Mestelman S, Muller A, Nuscheler R,. 2007. Public and private health care financing with alternate public rationing rules. Department of Economics Working Papers 2007-07, McMaster University.
3. Devlin N, Parkin D,. 2004. Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. Health Economics 13 (5): 437-452. (Pubitemid 38660393)
4. Ferner R, McDowell S,. 2009. A model for NICE in the US. British Medical Journal 338: b2221. DOI: 10.1136/bmj.b2221.
5. Fossati A, Levaggi R,. 2008. Delay is Not the Answer: Waiting Time in Health Care & Income Redistribution. Available from: http://ssrn.com/ abstract=1081928.
6. Gouveia M,. 1995. Majority rule and the public provision of private goods. Public Choice 93: 221-224.
7. Grassi S, Ma CA,. 2007. Subsidy Design and asymmetric information: wealth versus benefits. Department of Economics Working Papers Series WP2007-033, Boston University.
8. Hoel M,. 2007. What should (public) health insurance cover? Journal of Health Economics 26 (2): 251-262. (Pubitemid 46283047)
9. Jacobzone S,. 2000. Pharmaceutical policies in OECD: reconciling social and industrial goals. OECD Labour Market and Social Policy, occasional papers.
10. KCE. 2008. Threshold values for cost-effectiveness in health care. KCE Reports 100C. Bruxelles.
11. Levaggi L, Levaggi R,. 2006. Optimal copayment strategies in a public health care system. Available from: http://ssrn.com/abstract=734923.
12. McCabe C, Claxton K, Culyer AJ,. 2008. The NICE cost-effectiveness threshold: what it is and what that means. Pharmaco Economics 26 (9): 733-744.
13. Newman PJ,. 2005. Using Cost Effectiveness Analysis to Improve Health Care: Opportunities and Barriers. Oxford University Press: Oxford.
14. Schlander M,. 2008. The use of cost-effectiveness by the National Institute for Health and Clinical Excellence (NICE): no(t yet an) exemplar of a deliberative process. Journal of Medical Ethics 8 (34): 534-539.
15. Smith P,. 2005. User charges and priority setting in health care: balancing equity and efficiency. Journal of Health Economics 24: 1018-1029. (Pubitemid 41207908)
16. Viscusi WK, Evans WN,. 1990. Utility functions that depend on health status: estimates and economic implications. American Economic Review 80: 353-374.